Using cBioportal to examine melanoma genomes, revealed PTPRκ homozygous deletions in 3% of cutaneous melanoma samples as well as missense and non-sense mutations in 14% of cases (Fig. 10a). Here, PTPRK is linked to cutaneous melanoma.